DrugPatentWatch Database Preview
TRASICOR Drug Profile
» See Plans and Pricing
When do Trasicor patents expire, and what generic alternatives are available?
Trasicor is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in TRASICOR is oxprenolol hydrochloride. There is one drug master file entry for this compound. Additional details are available on the oxprenolol hydrochloride profile page.
Summary for TRASICOR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Bulk Api Vendors: | 60 |
Patent Applications: | 451 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRASICOR at DailyMed |

US Patents and Regulatory Information for TRASICOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-001 | Dec 28, 1983 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-004 | Dec 28, 1983 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-002 | Dec 28, 1983 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-003 | Dec 28, 1983 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRASICOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-002 | Dec 28, 1983 | Start Trial | Start Trial |
Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-003 | Dec 28, 1983 | Start Trial | Start Trial |
Novartis | TRASICOR | oxprenolol hydrochloride | CAPSULE;ORAL | 018166-004 | Dec 28, 1983 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TRASICOR
Country | Patent Number | Estimated Expiration |
---|---|---|
France | 1463034 | Start Trial |
United Kingdom | 1079608 | Start Trial |
Netherlands | 6511785 | Start Trial |
Netherlands | 130749 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |